Literature DB >> 22855490

Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.

Alexander M Price1, Jason P Tourigny, Eleonora Forte, Raul E Salinas, Sandeep S Dave, Micah A Luftig.   

Abstract

Epstein-Barr virus (EBV) is an oncogenic human herpesvirus that dramatically reorganizes host gene expression to immortalize primary B cells. In this study, we analyzed EBV-regulated host gene expression changes following primary B-cell infection, both during initial proliferation and through transformation into lymphoblastoid cell lines (LCLs). While most EBV-regulated mRNAs were changed during the transition from resting, uninfected B cells through initial B-cell proliferation, a substantial number of mRNAs changed uniquely from early proliferation through LCL outgrowth. We identified constitutively and dynamically EBV-regulated biological processes, protein classes, and targets of specific transcription factors. Early after infection, genes associated with proliferation, stress responses, and the p53 pathway were highly enriched. However, the transition from early to long-term outgrowth was characterized by genes involved in the inhibition of apoptosis, the actin cytoskeleton, and NF-κB activity. It was previously thought that the major viral protein responsible for NF-κB activation, latent membrane protein 1 (LMP1), is expressed within 2 days after infection. Our data indicate that while this is true, LCL-level LMP1 expression and NF-κB activity are not evident until 3 weeks after primary B-cell infection. Furthermore, heterologous NF-κB activation during the first week after infection increased the transformation efficiency, while early NF-κB inhibition had no effect on transformation. Rather, inhibition of NF-κB was not toxic to EBV-infected cells until LMP1 levels and NF-κB activity were high. These data collectively highlight the dynamic nature of EBV-regulated host gene expression and support the notion that early EBV-infected proliferating B cells have a fundamentally distinct growth and survival phenotype from that of LCLs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855490      PMCID: PMC3457162          DOI: 10.1128/JVI.01069-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Molecular diagnosis of Burkitt's lymphoma.

Authors:  Sandeep S Dave; Kai Fu; George W Wright; Lloyd T Lam; Philip Kluin; Evert-Jan Boerma; Timothy C Greiner; Dennis D Weisenburger; Andreas Rosenwald; German Ott; Hans-Konrad Müller-Hermelink; Randy D Gascoyne; Jan Delabie; Lisa M Rimsza; Rita M Braziel; Thomas M Grogan; Elias Campo; Elaine S Jaffe; Bhavana J Dave; Warren Sanger; Martin Bast; Julie M Vose; James O Armitage; Joseph M Connors; Erlend B Smeland; Stein Kvaloy; Harald Holte; Richard I Fisher; Thomas P Miller; Emilio Montserrat; Wyndham H Wilson; Manisha Bahl; Hong Zhao; Liming Yang; John Powell; Richard Simon; Wing C Chan; Louis M Staudt
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

2.  GenePattern 2.0.

Authors:  Michael Reich; Ted Liefeld; Joshua Gould; Jim Lerner; Pablo Tamayo; Jill P Mesirov
Journal:  Nat Genet       Date:  2006-05       Impact factor: 38.330

3.  Cellular target genes of Epstein-Barr virus nuclear antigen 2.

Authors:  Sabine Maier; Gabriele Staffler; Andrea Hartmann; Julia Höck; Karen Henning; Kristina Grabusic; Reinhard Mailhammer; Reinhard Hoffmann; Matthias Wilmanns; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Modulation of LMP1 protein expression by EBV-encoded microRNAs.

Authors:  Angela Kwok Fung Lo; Ka Fai To; Kwok Wai Lo; Raymond Wai Ming Lung; Jan Wai Ying Hui; Gangling Liao; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

5.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

6.  Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells.

Authors:  Lindsay C Spender; Walter Lucchesi; Gustavo Bodelon; Antonio Bilancio; Claudio Elgueta Karstegl; Tomoichiro Asano; Oliver Dittrich-Breiholz; Michael Kracht; Bart Vanhaesebroeck; Paul J Farrell
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

7.  Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.

Authors:  Markus Altmann; Dagmar Pich; Romana Ruiss; Jindong Wang; Bill Sugden; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

8.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

9.  Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.

Authors:  Markus Altmann; Wolfgang Hammerschmidt
Journal:  PLoS Biol       Date:  2005-11-15       Impact factor: 8.029

10.  PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways.

Authors:  Huaiyu Mi; Nan Guo; Anish Kejariwal; Paul D Thomas
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

View more
  50 in total

Review 1.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.

Authors:  Nicholas J Homa; Raul Salinas; Eleonora Forte; Timothy J Robinson; Mariano A Garcia-Blanco; Micah A Luftig
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.

Authors:  James C Romero-Masters; Makoto Ohashi; Reza Djavadian; Mark R Eichelberg; Mitchell Hayes; Nicholas A Zumwalde; Jillian A Bristol; Scott E Nelson; Shidong Ma; Erik A Ranheim; Jenny E Gumperz; Eric C Johannsen; Shannon C Kenney
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

4.  Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.

Authors:  Shi-Dong Ma; Ming-Han Tsai; James C Romero-Masters; Erik A Ranheim; Shane M Huebner; Jillian A Bristol; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

5.  Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.

Authors:  Mohamed S Arredouani; Manoj K Bhasin; David R Sage; Laura K Dunn; Michael B Gill; Deep Agnani; Towia A Libermann; Joyce D Fingeroth
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 6.  Epstein-Barr Virus LMP1-Mediated Oncogenicity.

Authors:  Liang Wei Wang; Sizun Jiang; Benjamin E Gewurz
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

7.  Evolutionary conservation of primate lymphocryptovirus microRNA targets.

Authors:  Rebecca L Skalsky; Dong Kang; Sarah D Linnstaedt; Bryan R Cullen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

8.  c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.

Authors:  Alexander M Price; Joshua E Messinger; Micah A Luftig
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

9.  Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.

Authors:  Abhik Saha; Hem C Jha; Santosh K Upadhyay; Erle S Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 10.  Interplay between DNA tumor viruses and the host DNA damage response.

Authors:  Karyn McFadden; Micah A Luftig
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.